Invest in Canada’s Largest Chain of MMJ Clinics


Ryan Allway

May 1st, 2017

News, Top News


Canada’s cannabis industry is expected to surpass $22 billion over the coming years, according to industry analysts, which has created numerous opportunities for investors. While licensed producers like Canopy Growth Corp. (TSX: WEED) may garner a lot of attention, investors may also want to consider medical marijuana clinics that take advantage of existing insurance schemes to provide patients with free and high-quality care.

In this article, we will take a look at Canabo Medical Inc.’s (TSX-V: CMM) (OTCQB: CAMDF) nationwide network of medical marijuana clinics and why investors should consider the stock.

Leader in MMJ Clinics

Canabo Medical owns and operates 16 clinics throughout Canada with over 40 licensed physicians and over 10,000 patients seen since inception. As a referral-only clinic, the costs for patient interaction are fully recoverable from the Provincial Health Departments and the medical cannabis purchased is tax deductible. The clinics are also fully-independent which helps ensure that patients get unbiased advice.

The patients referred to the clinic are treated for many different underlying conditions where medical marijuana could be beneficial. According to the company’s own analysis, there are more than 17.4 million individuals suffering from applicable medical conditions, including chronic pain, arthritis, migraines, fibromyalgia, anxiety, insomnia, Parkinson’s, epilepsy, multiple sclerosis, cancer, and Crohn’s disease, among others.

In addition to treating patients, the company maintains a complete database on all patients, including their medical condition, market demographics, and treatment efficacy. The company generates incremental revenue by offering access to this data via annual subscriptions or one-off analysis assignments to companies and researchers in the space. The company also provides consulting services to insurance and employer industries on cannabinoids.

Strong Financial Condition

Canabo Medical reported revenue of $1,552,583 and gross profit of $834,869 during its fiscal year ending on October 31, 2016. Management expects to achieve significant revenue growth moving into 2017 as it ramps up its operations, while breaking even on a net income basis by the fiscal second quarter of this year. By the end of next year, the company aims to achieve quarterly revenue that approaches $3 million.

The company plans to support this top- and bottom-line growth by opening new clinics in addition to its 16 clinics in Toronto, Barrie, Ottawa, Stoney Creek, Burlington, Halifax, St. John’s, Kingston, Kelowna, Chilliwack, St. Catherine’s, London, Moncton, Edmonton, Calgary, and Hamilton . With nearly $9 million in cash on its balance sheet, the company is well-positioned to execute this growth strategy with limited dilution for existing shareholders.

In addition to its clinics, the company recently completed a study that leverages its patient database information. The observational study showed that, among other things, 40% of patients prescribed medical marijuana for the treatment of pain and anxiety eliminated their use of benzodiazepines (a class of tranquilizers including Valium and Xanax) within 90 days. The widespread publication of studies like these could raise awareness for the database solution and increase both data licensing and consulting opportunities across academia and the corporate sector.

Seasoned Management Team

Canabo Medical has a seasoned management team with significant experience in developing networks of clinics, efficiently running clinical businesses, and in medical marijuana.

Executive Chairman Dr. Neil Smith is a leading Otolaryngologist Head and Neck Surgeon and a founder and principal of a sleep apnea company with 14 clinics located throughout Atlantic Canada. In addition to being a medical doctor, Dr. Smith’s experience in founding and growing a sleep apnea clinic to 14 locations is directly applicable to the company’s goals of opening medical marijuana clinics throughout the country.

President & CEO John Philpott has two decades of experience in the medical field, including serving as CEO of a leading North American physician recruitment firm. His background also includes improving clinic operational efficiencies in senior management roles. Mr. Philpott’s experience in recruiting could play a big role in helping Canabo attract top talent to its growing network of clinics, while his management experience should ensure their smooth operation.

Co-Founder Dr. Danial Schecter is a practicing family physician that brings a wealth of experience in the medical marijuana industry. After studying and working alongside leading medical marijuana researchers, Dr. Schecter has quickly become recognized as a leading expert in the field and is a frequent guest speaker. This notoriety helps greatly enhance the company’s brand as a leader in high quality medical marijuana-related care.

Looking Ahead

Canabo Medical Inc. (TSX-V: CMM) (OTCQB: CAMDF) represents a compelling investment opportunity in Canada’s cannabis industry. The company’s win-win business model has already started generating significant revenue growth with near-term profitability, while management’s significant experience helps ensure its ongoing success.

For more information, visit the company’s website at www.canabocorp.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading